1,219
Views
3
CrossRef citations to date
0
Altmetric
Letter

Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi

, & ORCID Icon
Pages 397-399 | Received 15 Apr 2020, Accepted 19 May 2020, Published online: 23 Jun 2020

References

  • United Nations Inter-agency Group for Child Mortality Estimation. Levels & trends in child mortality: report 2019, Estimates developed by the United Nations Inter-agency group for child mortality estimation. New York, NY: United Nations Fund; 2019.
  • 2018 Assessment report of the Global Vaccine Action Plan. Strategic advisory group of experts on immunization. Geneva, Switzerland: World Health Organization; 2018.
  • World Health Organization. Global vaccine action plan 2011–2020, 2013.
  • Mihigo R, Okeibunor J, Anya B, Mkanda P, Zawaira F. Challenges of immunization in the African Region. Pan Afr Med J. 2017;27(Suppl 3):12. doi:10.11604/pamj.supp.2017.27.3.12127.
  • Ntenda PAM. Factors associated with non- and under-vaccination among children aged 12–23 months in Malawi. A multinomial analysis of the population-based sample. Pediatr Neonatol. 2019;60(6):623–33. doi:10.1016/j.pedneo.2019.03.005.
  • Bondo A, Nambiar B, Lufesi N, Deula R, King C, Masache G, Makwenda C, Costello A, Rhoda D, McCollum ED, et al. An assessment of PCV13 vaccine coverage using a repeated cross-sectional household survey in Malawi. Gates Open Res. 2018;2:37. doi:10.12688/gatesopenres.12837.1.
  • Malawi: World Health Organization and United Nations Children’s Fund estimates of immunization coverage. 2018. revision, data received as of June 28, 2019, July 2, 2019.
  • Ginsburg AS, May SJ, Nkwopara E, Ambler G, McCollum ED, Mvalo T, Phiri A, Lufesi N, Sadruddin S. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol. BMC Infect Dis. 2018;18(1):476. doi:10.1186/s12879-018-3109-6.
  • Ginsburg AS, May S, Nkwopara E, Ambler G, McCollum ED, Mvalo T, Phiri A, Lufesi N. Clinical outcomes of pneumonia and other comorbidities in children aged 2–59 months in Lilongwe, Malawi: protocol for the prospective observational study “innovative treatments in pneumonia”. JMIR Res Protoc. 2019;8(7):e13377. doi:10.2196/13377.
  • Ginsburg AS, Mvalo T, Nkwopara E, McCollum ED, Ndamala CB, Schmicker R, Phiri A, Lufesi N, Izadnegahdar R, May S. Placebo vs amoxicillin for nonsevere fast-breathing pneumonia in Malawian children aged 2 to 59 months: a double-blind, randomized clinical noninferiority trial. JAMA Pediatr. 2019;173(1):21–28. doi:10.1001/jamapediatrics.2018.3407.
  • GAVI Joint Appraisal Malawi. 2018. [Access 14 April 2020]. https://www.gavi.org/country-documents/malawi
  • Mvula H, Heinsbroek E, Chihana M, Crampin AC, Kabuluzi S, Chirwa G, Mwansambo C, Costello A, Cunliffe NA, RS H, et al. Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural Malawi: a population cohort study. PLoS One. 2016;11(5):e0154997. doi:10.1371/journal.pone.0154997.
  • Okeibunor JC, Ogbuanu I, Blanche A, Chiwaya K, Chirwa G, Machekanyanga Z, Mihigo R, Zawaira F. Towards a strategy for reducing missed opportunities for vaccination in Malawi: implications of a qualitative health facility assessment. J Immunol Sci. 2018;2(Suppl(7)):46–54. doi:10.29245/2578-3009/2018/si.1107.